Viewing StudyNCT00087711



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00087711
Status: COMPLETED
Last Update Posted: 2019-09-12
First Post: 2004-07-12

Brief Title: A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer
Sponsor: Eli Lilly and Company
Organization: Eli Lilly and Company

Conditions & Keywords Data

Conditions:
Name
Non Small Cell Lung Carcinoma
Keywords: